LIVN News and Press, LivaNova PLC From 11/12/21

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, commented on the decision delivered today by the Court of Appeal of Milan (CoA) for LivaNova to pay damages in the amount of €453 million (approximately U.S. $519 million) as a result of a civ...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference (Stifel) and at the Jefferies 2021 London Healthcare Conference (Jefferies). ...

Company leadership to present long-range business plan, along with overviews on franchises and strategic pipeline initiatives LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it will host a virtual Investor Day on Decemb...

LivaNova PLC (LIVN) Q3 2021 Earnings Conference Call November 3, 2021 08:00 ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stif...

The following slide deck was published by LivaNova PLC in conjunction with their 2021 Q3 earnings call. For further details see: LivaNova PLC 2021 Q3 - Results - Earnings Call Presentation

LivaNova (LIVN +13.4%) has climbed more than a tenth to record the biggest intra-day gain since March 2020 after the company exceeded forecasts with its Q3 2021 financials and the updated earnings guidance beat the consensus. During the quarter, the worldwide sales from continuing operat...

Image source: The Motley Fool. LivaNova PLC (NASDAQ: LIVN) Q3 2021 Earnings Call Nov 3, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: LivaNova PLC (LIVN) Q3 2021 Earnings Call Transcript

LivaNova PLC (NASDAQ:LIVN): Q3 Non-GAAP EPS of $0.68 beats by $0.24; GAAP EPS of -$0.82 misses by $0.87. Revenue of $253.2M (+5.5% Y/Y) beats by $7.96M. Press Release For further details see: LivaNova PLC EPS beats by $0.24, beats on revenue

LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2021. For the third quarter of 2021, worldwide sales from continuing operations were $253.2 million, an increase of 5.5 percent on a re...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2021 results on Wednesday, November 3, 2021 at 12 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its third quarter ...